Kinetics of glycogen synthase kinase (GSK)3β and phosphorylated GSK3β (Ser 9) expression in experimentally induced periapical lesions

International Endodontic Journal

Volumn 47, Issue 12, 2014, Pages 1107-1116

  Sun, Z ^a   Wang, L ^a   Peng, B ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

GSK3 ; Inflammation; Osteoclast; P GSK3 (Ser 9); Periapical lesions

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA;

ANIMAL; KINETICS; MALE; METABOLISM; MICRO-COMPUTED TOMOGRAPHY; PATHOLOGY; PHOSPHORYLATION; RAT; TOOTH APEX; WISTAR RAT;

ANIMALS; GLYCOGEN SYNTHASE KINASE 3; KINETICS; MALE; PHOSPHORYLATION; RATS; RATS, WISTAR; TOOTH APEX; X-RAY MICROTOMOGRAPHY;

EID: 84939253621     PISSN: 01432885     EISSN: 13652591     Source Type: Journal    
DOI: 10.1111/iej.12258     Document Type: Article

References (38)

1. Adamowicz K, Wang H, Jotwani R et al. (2012) Inhibition of GSK3 abolishes bacterial-induced periodontal bone loss in mice. Molecular Medicine 18, 1190-6.
2. Aggarwal V, Logani A, Shah N (2008) The evaluation of computed tomography scans and ultrasounds in the differential diagnosis of periapical lesions. Journal of Endodontics 34, 1312-5.
3. Ataoglu T, Ungor M, Serpek B et al. (2002) Interleukin-1beta and tumour necrosis factor-alpha levels in periapical exudates. International Endodontic Journal 35, 181-5.
4. Balto K, Muller R, Carrington DC et al. (2000) Quantification of periapical bone destruction in mice by micro-computed tomography. Journal of Dental Research 79, 35-40.
5. Beurel E, Michalek SM, Jope RS (2010) Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3). Trends in Immunology 31, 24-31.
6. Cohen P, Goedert M (2004) GSK3 inhibitors: development and therapeutic potential. Nature Reviews Drug Discovery 3, 479-87.
7. Cuzzocrea S, Mazzon E, Paola RD et al. (2006) Glycogen synthase kinase-3β inhibition attenuates the degree of arthritis caused by type II collagen in the mouse. Clinical Immunology 120, 57-67.
8. Doble BW, Woodgett JR (2003) GSK-3: tricks of the trade for a multitasking kinase. Journal of Cell Science 116, 1175-86.
9. Dugo L, Collin M, Allen DA et al. (2005) GSK-3beta inhibitors attenuate the organ injury/dysfunction caused by endotoxemia in the rat. Critical Care Medicine 33, 1903-12.
10. Gong R, Ge Y, Chen S et al. (2008) Glycogen synthase kinase 3β: a novel marker and modulator of inflammatory injury in chronic renal allograft disease. American Journal of Transplantation 8, 1852-63.
11. Jang HD, Shin JH, Park DR et al. (2011) Inactivation of glycogen synthase kinase-3 is required for osteoclast differentiation. The Journal of Biological Chemistry 286, 39043-50.
12. Jope RS, Johnson GV (2004) The glamour and gloom of glycogen synthase kinase-3. Trends in Biochemical Sciences 29, 95-102.
13. Jope RS, Yuskaitis CJ, Beurel E (2007) Glycogen synthase kinase-3 (GSK3) inflammation, diseases, and therapeutics. Neurochemical Research 32, 577-95.
14. Kawashima N, Okiji T, Kosaka T, Suda H (1996) Kinetics of macrophages and lymphoid cells during the development of experimentally induced periapical lesions in rat molars: a quantitative immunohistochemical study. Journal of Endodontics 22, 311-6.
15. Kawashima N, Suzuki N, Yang G et al. (2007) Kinetics of RANKL, RANK and OPG expressions in experimentally induced rat periapical lesions. Oral Surgery, Oral Medicine, and Oral Pathology 103, 707-11.
16. Liapatas S, Nakou M, Rontogianni D (2003) Inflammatory infiltrate of chronic periradicular lesions: an immunohistochemical study. International Endodontic Journal 36, 464-71.
17. Martin M, Rehani K, Jope RS et al. (2005) Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nature Immunology 6, 777-84.
18. Márton IJ, Kiss C (2000) Protective and destructive immune reactions in apical periodontitis. Oral microbiology and immunology 15, 139-50.
19. Moon JB, Kim JH, Kim K et al. (2012) Akt induces osteoclast differentiation through regulating the GSK3β/NFATc1 signaling cascade. The Journal of Immunology 188, 163-9.
20. Muller R, Van Campenhout H, Van Damme B et al. (1998) Morphometric analysis of human bone biopsies: a quantitative structural comparison of histological sections and micro-computed tomography. Bone 23, 59-66.
21. Nair PN (2004) Pathogenesis of apical periodontitis and the causes of endodontic failures. Critical Reviews in Oral Biology & Medicine 15, 348-81.
22. Queiroz-Junior CM, Silva MJB, Madeira MFM et al. (2010) A controversial role for IL-12 in immune response and bone resorption at apical periodontal sites. Clinical and Developmental Immunology 2010, 1-8.
23. Rayasam GV, Tulasi VK, Sodhi R et al. (2009) Glycogen synthase kinase 3: more than a namesake. British Journal of Pharmacology 156, 885-98.
24. Stashenko P, Yu SM (1989) T helper and T suppressor cell reversal during the development of induced rat periapical lesions. Journal of Dental Research 68, 830-4.
25. Stashenko P, Wang CY, Tani-Ishii N et al. (1994) Pathogenesis of induced rat periapical lesions. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology & Endodontics 78, 494-502.
26. Stashenko P, Teles R, D'Souza R (1998) Periapical inflammatory responses and their Modulation. Critical Reviews in Oral Biology & Medicine 9, 498-521.
27. Sugden PH, Fuller SJ, Weiss SC et al. (2008) Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis. British Journal of Pharmacology 153(Suppl. 1), S137-53.
28. Takada Y, Singh S, Aggarwal BB (2004) Identification of a p65 peptide that selectively inhibits NF-kappa B activation induced by various inflammatory stimuli and its role in down-regulation of NF-kappa B-mediated gene expression and up-regulation of apoptosis. The Journal of Biological Chemistry 279, 15096-104.
29. Takahashi K (1998) Microbiological, pathological, inflammatory, immunological and molecular biological aspects of periradicular disease. International Endodontic Journal 31, 311-25.
30. Wang L, Zhang R, Peng B (2009) Expression of a novel PDGF isoform, PDGF-C, in experimental periapical lesions. Journal of Endodontics 35, 377-81.
31. Whittle BJ, Varga C, Posa A et al. (2006) Reduction of experimental colitis in the rat by inhibitors of glycogen synthase kinase-3β. British Journal of Pharmacology 147, 575-82.
32. Woodgett JR (1991) cDNA cloning and properties of glycogen synthase kinase-3. Methods in Enzymology 200, 564-77.
33. Woodgett JR, Ohashi PS (2005) GSK3: an in-Toll-erant protein kinase? Nature Immunology 6, 751-2.
34. Wu D, Pan W (2010) GSK3: a multifaceted kinase in Wnt signaling. Trends in Biochemical Sciences 35, 161-8.
35. Yamasaki M, Kumazawa M, Kohsaka T, Nakamura H (1994) Effect of methotrexate-induced neutropenia on rat periapical lesion. Oral Surgery, Oral Medicine, and Oral Pathology 77(6), 655-61.
36. Yang J, Peng B (2008) Correlation between the expression of c-Fos and osteoclasts in induced periapical lesions in rats. Journal of Endodontics 34, 22-5.
37. Yang S, Zhu L, Xiao L et al. (2014) Imbalance of interleukin-17 + T-cell and Foxp3 + regulatory T-cell dynamics in rat periapical lesions. Journal of Endodontics 40, 56-62.
38. Zhang X, Peng B (2005) Immunolocalization of receptor activator of NF kappa B ligand in rat periapical lesions. Journal of Endodontics 31, 574-7.